Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-19-000434
Filing Date
2019-01-03
Accepted
2019-01-03 08:08:58
Documents
1
Period of Report
2018-08-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 2553
  Complete submission text file 0001127602-19-000434.txt   3923
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 CONNELL DRIVE BERKELEY HEIGHTS NJ 07922
Business Address
Wyant Alyssa (Reporting) CIK: 0001698765 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37568 | Film No.: 19503665